These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 20160875)

  • 1. Adenoviral vector-based strategies for cancer therapy.
    Sharma A; Tandon M; Bangari DS; Mittal SK
    Curr Drug ther; 2009 May; 4(2):117-138. PubMed ID: 20160875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies and future directions for eluding adenoviral vector immunity.
    Bangari DS; Mittal SK
    Curr Gene Ther; 2006 Apr; 6(2):215-26. PubMed ID: 16611043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
    Iampietro MJ; Larocca RA; Provine NM; Abbink P; Kang ZH; Bricault CA; Barouch DH
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral-mediated gene transfer for cancer treatment.
    Wilson DR
    Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral vectors: a promising tool for gene therapy.
    Ghosh SS; Gopinath P; Ramesh A
    Appl Biochem Biotechnol; 2006 Apr; 133(1):9-29. PubMed ID: 16622281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of adenoviral vectors for gene therapy of cancer.
    Zhang WW
    Cancer Gene Ther; 1999; 6(2):113-38. PubMed ID: 10195879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current advances and future challenges in Adenoviral vector biology and targeting.
    Campos SK; Barry MA
    Curr Gene Ther; 2007 Jun; 7(3):189-204. PubMed ID: 17584037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current developments in adenovirus-based cancer gene therapy.
    Rein DT; Breidenbach M; Curiel DT
    Future Oncol; 2006 Feb; 2(1):137-43. PubMed ID: 16556080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture.
    Bangari DS; Shukla S; Mittal SK
    Biochem Biophys Res Commun; 2005 Feb; 327(3):960-6. PubMed ID: 15649439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
    Liu Y; Ye T; Maynard J; Akbulut H; Deisseroth A
    Cancer Gene Ther; 2006 Apr; 13(4):346-56. PubMed ID: 16179927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy progress and prospects: adenoviral vectors.
    St George JA
    Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism.
    Sun Y; Lv X; Ding P; Wang L; Sun Y; Li S; Zhang H; Gao Z
    Acta Biomater; 2019 Oct; 97():93-104. PubMed ID: 31386928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
    Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
    Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.
    Wirth T; Zender L; Schulte B; Mundt B; Plentz R; Rudolph KL; Manns M; Kubicka S; Kühnel F
    Cancer Res; 2003 Jun; 63(12):3181-8. PubMed ID: 12810646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished.
    van Beusechem VW; Grill J; Mastenbroek DC; Wickham TJ; Roelvink PW; Haisma HJ; Lamfers ML; Dirven CM; Pinedo HM; Gerritsen WR
    J Virol; 2002 Mar; 76(6):2753-62. PubMed ID: 11861842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-based cancer gene therapy.
    Kaplan JM
    Curr Gene Ther; 2005 Dec; 5(6):595-605. PubMed ID: 16457649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors.
    Rots MG; Curiel DT; Gerritsen WR; Haisma HJ
    J Control Release; 2003 Feb; 87(1-3):159-65. PubMed ID: 12618032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.
    Kruklitis RJ; Fishbein I; Singhal S; Kapoor V; Levy RJ; Alferiev IS; Sterman DH
    Respiration; 2014; 88(5):406-17. PubMed ID: 25323160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.